Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Bone Therapeutics SA
  6. Summary
    BOTHE   BE0974280126

BONE THERAPEUTICS SA

(BOTHE)
  Report
Real-time Euronext Bruxelles  -  08:57 2022-09-30 am EDT
0.1850 EUR   +2.78%
09/30BONE THERAPEUTICS SA : Monthly statement on voting rights
CO
09/07Bone Therapeutics reports half year 2022 results
GL
09/07BONE THERAPEUTICS SA : Half-year report
CO
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
0.1966(c) 0.199(c) 0.179(c) 0.18(c) 0.185(c) Last
163 950 2 860 55 776 73 400 35 025 Volume
-4.56% +1.22% -10.05% +0.56% +2.78% Change
More quotes
Estimated financial data (e)
Sales 2020 2,47 M 2,42 M 2,42 M
Net income 2020 -11,9 M -11,7 M -11,7 M
Net Debt 2020 0,15 M 0,15 M 0,15 M
P/E ratio 2020 -2,55x
Yield 2020 -
Sales 2021 2,08 M 2,04 M 2,04 M
Net income 2021 -12,9 M -12,7 M -12,7 M
Net Debt 2021 11,4 M 11,2 M 11,2 M
P/E ratio 2021 -0,87x
Yield 2021 -
Capitalization 4,33 M 4,24 M 4,24 M
EV / Sales 2020 17,4x
EV / Sales 2021 12,3x
Nbr of Employees 20
Free-Float 82,4%
More Financials
Company
Bone Therapeutics SA is a leading biotech company focused on the development of innovative products to address high unmet needs in orthopedics and other diseases. The Company has a diversified portfolio of cell therapies at different stages ranging from pre-clinical programs in immunomodulation to mid stage clinical development for orthopedic conditions, targeting markets with large unmet medical needs and limited... 
Sector
Pharmaceuticals
Calendar
10/05 | 08:00amShareholder meeting
More about the company
All news about BONE THERAPEUTICS SA
09/30BONE THERAPEUTICS SA : Monthly statement on voting rights
CO
09/07Bone Therapeutics reports half year 2022 results
GL
09/07BONE THERAPEUTICS SA : Half-year report
CO
09/07Bone Therapeutics SA Reports Earnings Results for the Half Year Ended June 30, 2022
CI
09/07Bone Therapeutics SA Reports Earnings Results for the Half Year Ended June 30, 2022
CI
09/07BONE THERAPEUTICS SA : 1st-half-year results
CO
09/05Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022
GL
09/05Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022
AQ
09/05BONE THERAPEUTICS SA : Extraordinary general shareholder meeting
CO
09/05BONE THERAPEUTICS SA : Extraordinary general shareholder meeting
CO
08/31BONE THERAPEUTICS SA : 1st-half-year results
CO
08/31BONE THERAPEUTICS SA : Monthly statement on voting rights
CO
08/26Bone Therapeutics to host Extraordinary General Meeting on 26 September 2022
GL
08/26BONE THERAPEUTICS SA : Extraordinary general shareholder meeting
CO
08/10Global markets live: Toshiba, Foxconn, Coinbase, Tesla, Meta...
MS
More news
News in other languages on BONE THERAPEUTICS SA
09/07Colruyt koploper op rode beurs
09/07Bel20 beperkt verlies dankzij Colruyt
09/07Les valeurs à suivre aujourd'hui à la Bourse de Paris - Mercredi 7 septembre 2022
09/07Ça glisse
09/07EN DIRECT DES MARCHES : Orange, Ubisoft, TF1, Neoen, Apple, Repsol..
More news
Analyst Recommendations on BONE THERAPEUTICS SA
More recommendations
Chart BONE THERAPEUTICS SA
Duration : Period :
Bone Therapeutics SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BONE THERAPEUTICS SA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,19 €
Average target price 2,50 €
Spread / Average Target 1 251%
Managers and Directors
Miguel Forte Chief Executive Officer & Director
Lieve Creten Chief Financial Officer
Baron Jean Stéphenne Chairman
Guy Heynen Chief Medical, Clinical & Regulatory Officer
Anthony Ting Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
BONE THERAPEUTICS SA-72.22%4
JOHNSON & JOHNSON-4.51%429 503
ELI LILLY AND COMPANY19.47%307 239
ROCHE HOLDING AG-14.68%271 055
PFIZER, INC.-25.89%245 597
ABBVIE INC.-0.88%237 296